Search for another bill
Search for another bill or initiative
SB 5240 - 2025-26
Concerning anaphylaxis medications in schools.
Current status:
SRules 3
Where is it in the process?
Bill status-at-a-glance
Current status:
SRules 3
Where is it in the process?
Bill history
2025 Regular Session
In the Senate
Jan 14
First reading, referred to Early Learning & K-12 Education.
(View original bill)
Jan 29
Public hearing in the Senate Committee on Early Learning & K-12 Education at 10:30 AM.
(Committee materials)
Feb 11
Executive action taken in the Senate Committee on Early Learning & K-12 Education at 8:00 AM.
(Committee materials)
EDU - Majority; 1st substitute bill be substituted, do pass.
(View 1st substitute)
(Majority report)
Feb 12
Passed to Rules Committee for second reading.
Mar 5
Placed on second reading by Rules Committee.
Mar 10
1st substitute bill substituted (EDU 25).
(View 1st substitute)
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
(View this roll call)
In the House
Mar 12
First reading, referred to Education.
Mar 18
Public hearing in the House Committee on Education at 4:00 PM.
(Committee materials)
Apr 27
By resolution, returned to Senate Rules Committee for third reading.
Available documents
For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.
Fiscal note
Amendments
Available videos